- $22 BnWorld market, 2023
- $30.7 BnProjected, 2033
- 3.4%Growth a year (CAGR)
- 472Active clinical trials worldwide
Largest countries
Market size in 2023 · growth a year to 2033
-
1
US
$9.2 Bn
1.4% a year · 42% of the world -
2
China
$1.8 Bn
4.9% a year · 8% of the world -
3
Canada
$1.8 Bn
3.4% a year · 8% of the world -
4
Japan
$1.4 Bn
3.9% a year · 6.2% of the world -
5
Germany
$805 Mn
1.6% a year · 3.7% of the world -
6
France
$605 Mn
2.4% a year · 2.8% of the world -
7
UK
$572 Mn
1.4% a year · 2.6% of the world -
8
Brazil
$550 Mn
4.4% a year · 2.5% of the world -
9
Italy
$528 Mn
2.9% a year · 2.4% of the world -
10
Ecuador
$440 Mn
4% a year · 2% of the world
Most clinical trials
Active trials by country (ClinicalTrials.gov)
See every trial on ClinicalTrials.gov (opens in a new tab)
Egypt
Spain
RussiaOver The Counter (OTC) Analgesics by country and region
India
Saudi Arabia
Mexico
Australia
South Africa
UAE
Philippines
Malaysia
Hong Kong
Singapore
Thailand
Kenya
New Zealand"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.
Latest research 813 papers since 2021
- Parents' identification of pain and use of analgesics during their infants' pain management at home and the role of AI-enabled digital solutions: a qualitative study. Pain management, 2026
- Multiple Organ Failure Secondary to Pancreatitis Due to Biliary Ascariasis in a Young Patient: A Case Report on the Importance of a Good Anamnesis. International medical case reports journal, 2026
- Prenatal exposure to paracetamol is associated with smaller testicular volume: a COPANA cohort study of 287 healthy infant boys. Human reproduction open, 2026
- Academic Discipline, Self-Medication, and Medication-Related Behaviors in Premenstrual Symptom Management Among Female University Students: A Cross-Sectional Study. Healthcare (Basel, Switzerland), 2026
- Prevalence and Associated Factors of Self-Medication Among Late Adolescents in Urban Dhaka, Bangladesh: A Cross-Sectional Study. Health science reports, 2026
Compare Over The Counter (OTC) Analgesics side by side
Key companies in Over The Counter (OTC) Analgesics
AstraZeneca PLC
Bayer AG
Boehringer Ingelheim International GmbH
GSK PLC
Johnson & Johnson
Merck & Co Inc
Novartis AG
Pfizer Inc
Reckitt Benckiser Group PLC
Sanofi SA
Sun Pharmaceutical Industries Ltd
Takeda Pharmaceutical COmpany Limited
Quick answers
How big is the Over The Counter (OTC) Analgesics market?
The world Over The Counter (OTC) Analgesics market was worth about $22 Bn in 2023 and is projected to reach $30.7 Bn by 2033, growing 3.4% a year (CAGR).
Which country has the largest Over The Counter (OTC) Analgesics market?
The US is the largest of the 24 countries we cover, at $9.2 Bn in 2023. India grows fastest, at 6.4% a year.
How many clinical trials are running in Over The Counter (OTC) Analgesics?
ClinicalTrials.gov lists 472 active trials worldwide (recruiting, about to start or running), most of them in the US, as of 10 Nov 2026.
How much research is published on Over The Counter (OTC) Analgesics?
PubMed lists about 813 papers on the topic since 2021.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.